Dr Rosendo Emilio Martinez, MD in Ponce, PR - Medicare Plastic And Reconstructive Surgery

Dr Rosendo Emilio Martinez, MD is a medicare enrolled "Plastic Surgery" physician in Ponce, Puerto Rico. He went to University Central Del Caribe Escuela De Medicina and graduated in 1980 and has 44 years of diverse experience with area of expertise as Plastic And Reconstructive Surgery. His current practice location is 2225 Ponce By Pass Suite 401, Ponce, Puerto Rico. You can reach out to his office (for appointments etc.) via phone at (787) 840-9450.

Dr Rosendo Emilio Martinez is licensed to practice in Puerto Rico (license number 8781) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1134189400.

Contact Information

	Dr Rosendo Emilio Martinez, MD
	2225 Ponce By Pass Suite 401, Ponce, PR 00717-1320
	(787) 840-9450
	(787) 840-9454

Physician's Profile

Full Name	Dr Rosendo Emilio Martinez
Gender	Male
Speciality	Plastic And Reconstructive Surgery
Experience	44 Years
Location	2225 Ponce By Pass Suite 401, Ponce, Puerto Rico
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Rosendo Emilio Martinez attended and graduated from University Central Del Caribe Escuela De Medicina in 1980

NPI Data:

NPI Number: 1134189400
Provider Enumeration Date: 03/23/2006
Last Update Date: 11/20/2017

Medicare PECOS Information:

PECOS PAC ID: 8123276193
Enrollment ID: I20120917000467

Medical Identifiers

Medical identifiers for Dr Rosendo Emilio Martinez such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1134189400	NPI	-	NPPES
660438128	Other	PR	CHAMPUS CHAMPVA
7310095	Other	PR	HUMANA
SE2581	Other	PR	PALI
660438128	Other	PR	TRICARE
338781	Other	PR	UIA
204167	Other	PR	UTI
660438128	Other	PR	AARP

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208200000X	Plastic Surgery	8781 (Puerto Rico)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Rosendo Emilio Martinez is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Rosendo Emilio Martinez, MD 2225 Ponce By Pass Suite 401, Ponce, PR 00717-1320 Ph: (787) 840-9450	Dr Rosendo Emilio Martinez, MD 2225 Ponce By Pass Suite 401, Ponce, PR 00717-1320 Ph: (787) 840-9450

News Archive

MonoSol Rx, Midatech collaborate to develop peptides for therapeutic delivery utilizing pharmaceutical films

MonoSol Rx, the developer of PharmFilm® drug delivery technology, today announced the expansion of its agreement with Midatech Group (Oxford, UK) to develop nanoparticle-based proteins and peptides for therapeutic delivery utilizing pharmaceutical films. Under the terms of the expanded agreement, MonoSol Rx has made an equity investment in Midatech and Keith Kendall, Executive Vice President and Chief Financial Officer of MonoSol Rx, will join the Midatech Board of Directors.

Merck to face New York State and New York City in joint lawsuit

The drug company Merck is facing joint action from New York State and New York City over the millions which were spent on health programs related to the drug Vioxx.

Blocking macrophage migration inhibitory factor molecule might prevent the progression of multiple sclerosis

A new study suggests that a substance made by immune cells plays a key role in the progression of a disease in animals that closely mimics multiple sclerosis (MS). The findings further suggest that blocking the molecule, known as macrophage migration inhibitory factor (MIF) might prevent the progression of the disease.

New article describes current state of asbestos use worldwide

Challenges to global health can evolve from policies and decisions that take years or decades to unfold. An article in the current issue of the Annals of Global Health describes the current state of asbestos use worldwide, a story that began over 100 years ago, and the real and contrived controversies regarding asbestos.

Dr Rosendo Emilio Martinez, MD - Medicare Plastic And Reconstructive Surgery in Ponce, PR